Home / Recalls / Lannett Company Inc. / D-0584-2026

D-0584-2026 Class II Ongoing

Recalled by Lannett Company Inc. — Seymour, IN

Recall Details

Product Type: Drugs
Report Date: June 10, 2026
Initiation Date: May 27, 2026
Termination Date: N/A
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 3984 bottles

Product Description

Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.

Reason for Recall

Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: 25282724A, Exp. Date 2027/01

Other recalls by Lannett Company Inc.

D-0533-2026 Class III — Primidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett (April 24, 2026)
D-0096-2026 Class II — Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, (October 10, 2025)
D-0642-2025 Class II — Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate a (August 19, 2025)
D-0599-2025 Class II — Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distrib (August 11, 2025)
D-0112-2025 Class II — Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, D (October 25, 2024)
D-0161-2023 Class III — Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 (November 9, 2022)
D-0160-2023 Class III — Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 (November 9, 2022)
D-0558-2022 Class II — Diazepam Oral Solution (Concentrate), 25 mg per 5 mL (5 mg/mL), 30 mL BOTTLE and (February 9, 2022)
D-1508-2020 Class II — Prednisone Tablets, USP 2.5 mg, 100 tablets, Rx only, Distributed by: Lannett C (August 10, 2020)
D-0630-2020 Class I — Levetiracetam Oral Solution 100mg/mL, 473 mL (16 fl. oz.) Bottles, Rx Only, Dist (December 6, 2019)